Statistics

Total Visits

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer117

Select a period of time:

Number of views in the range

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer37

Views

Views
December 20251
January 202611
February 20260
March 20266
April 20261
May 20262
June 202616
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Netherlands7
Argentina2
Australia1
Chile1
Colombia1
Finland1
France1
Hungary1
Ireland1
 

Top cities views

Views
San Jose8
Groningen7
Bracey1
Bucaramanga1
Burzaco1
Dublin1
Helsinki1
Istanbul1
Ituzaingó1
Melbourne1